Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease

Last updated: December 23, 2018
Sponsor: Services Hospital, Lahore
Overall Status: Completed

Phase

4

Condition

Hemorrhoids

Treatment

N/A

Clinical Study ID

NCT02782455
DD
  • Ages 13-80
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Haemorrhoids are vascular cushions in the anal canal that help in the control of stool. When inflamed they become pathological and may present with protrusion and bleeding. A randomized, triple blind , controlled study will be conducted to compare the efficacy of calcium dobesilate against flavanoids in the management of early haemorrhoidal disease.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Grade I and Grade II hemorrhoids

Exclusion

Exclusion Criteria:

  • CLD

  • colorectal/ anorectal Malignancy

  • self medication

  • local Quack Hakeem medication

  • pregnancy

Study Design

Total Participants: 100
Study Start date:
December 01, 2016
Estimated Completion Date:
November 30, 2018

Connect with a study center

  • Services Hospital Lahore

    Lahore, Punjab 54000
    Pakistan

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.